Terumo Corp (4543) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:Asia

Author(s):

Product Code:GDPH740D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

November 2018

Total pages

39

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company's systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.

Terumo Corp (4543)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Terumo Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Terumo Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9

Terumo Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Terumo Corp, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

UniCAR Enters into Agreement with Terumo BCT 11

Cognate Bioservices to Enter into Agreement with Terumo BCT 12

Terumo Enters into Distribution Agreement with Piramal Critical Care 13

Cognate Bioservices Enters into Agreement with Terumo BCT 14

Phosphagenics Enters into Agreement with Terumo 15

Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 16

Asset Transactions 17

Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For USD 56.5 Million 17

Acquisition 19

Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 19

Terumo BCT Acquires Medservice, Distributor Of Medical Products 20

Terumo Corp-Key Competitors 21

Terumo Corp-Key Employees 22

Terumo Corp-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Joint Venture 28

Recent Developments 29

Strategy And Business Planning 29

Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 29

Jan 31, 2017: Terumo Opens a Branch in Yangon 30

Financial Announcements 31

Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 31

Corporate Communications 32

Aug 16, 2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor 32

Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor 33

Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 34

Legal and Regulatory 36

Nov 14, 2018: Terumo announces GMP certification has been awarded for the manufacturing and filling of premixed intravenous solutions from the FDA (U.S.A.) 36

Other Significant Developments 37

Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 37

Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List of Figure

List of Figures

Terumo Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Terumo Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9


List of Table

List of Tables

Terumo Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Terumo Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Terumo Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Terumo Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Terumo Corp, Medical Devices Deals, 2012 to YTD 2018 9

Terumo Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

UniCAR Enters into Agreement with Terumo BCT 11

Cognate Bioservices to Enter into Agreement with Terumo BCT 12

Terumo Enters into Distribution Agreement with Piramal Critical Care 13

Cognate Bioservices Enters into Agreement with Terumo BCT 14

Phosphagenics Enters into Agreement with Terumo 15

Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 16

Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For USD 56.5 Million 17

Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 19

Terumo BCT Acquires Medservice, Distributor Of Medical Products 20

Terumo Corp, Key Competitors 21

Terumo Corp, Key Employees 22

Terumo Corp, Other Locations 25

Terumo Corp, Subsidiaries 26

Terumo Corp, Joint Venture 28

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022